{
    "clinical_study": {
        "@rank": "28351", 
        "arm_group": [
            {
                "arm_group_label": "Botox_A", 
                "arm_group_type": "Experimental", 
                "description": "receiving Botulinum Toxin Type-A (Botox-A, Allergan) at both affected lower extremity (aLE) and upper extremity (aUE)"
            }, 
            {
                "arm_group_label": "placebo_A", 
                "arm_group_type": "Placebo Comparator", 
                "description": "receiving placebo injection at both aLE & aUE ; receiving Botox-A at both aLE & aUE at 6-month."
            }, 
            {
                "arm_group_label": "Botox_B", 
                "arm_group_type": "Experimental", 
                "description": "receiving Botox-A injection at aLE and placebo injection (sterile normal saline) at aUE."
            }, 
            {
                "arm_group_label": "placebo_B", 
                "arm_group_type": "Placebo Comparator", 
                "description": "receiving placebo injection at both aLE & aUE ; receiving Botox-A only at aLE at 6-month."
            }
        ], 
        "brief_summary": {
            "textblock": "Spasticity, muscle weakness, abnormal gait pattern are co-morbidities commonly seen in\n      stroke patients. They cause disabled condition of patients in activities of daily life and\n      functional performance, and also accidental falls and subsequent fractures.\n\n      This study is to evaluate and compare the effects of different phase injection of Botulinum\n      Toxin Type-A at affected limbs on muscle rheological changes, muscle activity, muscle tone,\n      functional performance, gait pattern and energy consumption in stroke patients."
        }, 
        "brief_title": "Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Spasticity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Muscle Spasticity", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  first-ever stroke, with spasticity within 3-months (MAS=2~3)\n\n          -  independent walking 10 meters (with assistive devices)\n\n        Exclusion Criteria:\n\n          -  recurrent stroke, cognition impaired\n\n          -  lower limb fracture\n\n          -  received anti-spasticity injection in the past"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01817816", 
            "org_study_id": "CCH-061203"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Botox_A", 
                    "placebo_A"
                ], 
                "intervention_name": "Botox_A", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Botox_B", 
                    "placebo_B"
                ], 
                "intervention_name": "Botox_B", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Botulinum Toxins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 18, 2013", 
        "location": {
            "contact": {
                "last_name": "Tseng", 
                "phone": "886-4-7238595", 
                "phone_ext": "4077"
            }, 
            "facility": {
                "address": {
                    "city": "Taiwan", 
                    "country": "Taiwan", 
                    "state": "Changhua", 
                    "zip": "500"
                }, 
                "name": "Changhua Christian Hospital"
            }, 
            "investigator": {
                "last_name": "Tasen Wei", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "105546@cch.org.tw", 
            "last_name": "PengTa Liu", 
            "phone": "886-4-7238595", 
            "phone_ext": "7427"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "use modified Ashworth Scale to access elbow, wrist, ankle joint muscle tone 0: normal\nslight hypertonus, at the end-range 1+: mild hypertonus, catch when limb is moved (<1/2)\nmoderate hypertonus,, limbs moves easily (>1/2)\npassive movement difficult\nrigid", 
            "measure": "Change in the muscle tone in upper and lower extremity", 
            "safety_issue": "Yes", 
            "time_frame": "4 weeks after injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01817816"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Changhua Christian Hospital", 
            "investigator_full_name": "Ta-Sen Wei,MD", 
            "investigator_title": "Director, Physical Medical and Rehabilitation, Principal Investigator, Clinical Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Change in the gait pattern as walking", 
            "safety_issue": "Yes", 
            "time_frame": "4 weeks after intervention"
        }, 
        "source": "Changhua Christian Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Changhua Christian Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}